Structure-based drug design: progress, results and challenges
Open Access
- 1 July 1994
- journal article
- review article
- Published by Elsevier BV in Structure
- Vol. 2 (7), 577-587
- https://doi.org/10.1016/s0969-2126(00)00060-5
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Theory of macromolecule-ligand interactionsCurrent Opinion in Structural Biology, 1994
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994
- Ligand docking to proteins with discrete side-chain flexibilityJournal of Molecular Biology, 1994
- Turn-of-the-century electron microscopyCurrent Biology, 1993
- Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1Nature, 1993
- Experimental system for similarity and 3D searching of CAS registry substances. 1. 3D substructure searchingJournal of Chemical Information and Computer Sciences, 1993
- A Comparison of the Anti-rhinoviral Drug Binding Pocket in HRV14 and HRV1AJournal of Molecular Biology, 1993
- Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitorsBiochemistry, 1992
- The development of versions 3 and 4 of the Cambridge Structural Database SystemJournal of Chemical Information and Computer Sciences, 1991
- A geometric approach to macromolecule-ligand interactionsJournal of Molecular Biology, 1982